Altre lingue Jubilant Pharmova Limited NSE India S.E.

Azioni

JUBLPHARMA

INE700A01033

Tempo differito NSE India S.E. Altri mercati azionari 12:24:35 16/07/2024			Variaz. 5gg	Var. 1 gen.
738,8 ^INR	+1,78%		+0,93%	+35,44%

18/06	Jubilant Pharmova riceve 15 osservazioni dalla FDA statunitense per l'impianto di produzione dell'unità in Canada; le azioni calano del 3%.	MT
17/06	L'unità Jubilant Pharmova anticipa un prestito a termine di 75 milioni di dollari	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Jubilant Pharmova : Related Party Disclosure – 31.03.2024	10/07
Jubilant Pharmova Arm Completes Prepayment of $75 Million Term Loan	25/06
Jubilant Pharmova Gets 15 Observations from US FDA for Unit's Manufacturing Facility in Canada; Shares Dip 3%	18/06
Jubilant Pharmova Unit to Prepay $75 Million Term Loan	17/06
Jubilant Pharma Unit to Invest $50 Million for PET Radiopharmacy Network Expansion in US	17/06
Jubilant Pharmova Gets Three US FDA Observations for Unit's Facility in Washington; Shares Drop 3%	10/06
Jubilant Pharmova Narrows Loss in Fiscal Q4	30/05
Jubilant Pharmova : Chairmen’s Message	29/05
Jubilant Pharmova : FAQ’s	29/05
India's Jubilant Pharmova reports narrower fourth-quarter loss	29/05
Jubilant Pharmova Limited Announces Resignation of Jinang Pratap Parekh as Whole-Time Director, Effective May 31, 2024	29/05
Jubilant Pharmova Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024	29/05
Jubilant Pharmova Limited Reports Earnings Results for the Full Year Ended March 31, 2024	29/05
Jubilant Pharmova Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	29/05
Jubilant Pharmova Appoints CEO for Radiopharma Business	03/05
Jubilant Pharmova Limited Receives Rectification Application Against Certain Tax Demands Raised by the Income Tax Department for Assessment Year 2015- 16	30/04
Jubilant Pharmova Subsidiary's Canadian Manufacturing Unit Gets Five Observations from US FDA	25/04
Jubilant Pharmova Unit Gets VAI Status for Roorkee, India Facility	17/04
Jubilant Pharmova : Investor Presentation- March 12, 2024	06/03
India's Jubilant Pharmova posts quarterly profit	02/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Jubilant Pharmova Limited NSE India S.E.

Azioni

JUBLPHARMA

INE700A01033

Altre lingue

Filtri